SURFIX BV

Their core work

SURFIX BV is a Dutch deep-tech SME specializing in photonic biosensing platforms — they build miniaturized optical sensor chips that detect biological targets (pathogens, cancer biomarkers) with high sensitivity. Their core value is translating laboratory photonics — specifically asymmetric Mach-Zehnder Interferometer (aMZI) architectures — into manufacturable, field-deployable diagnostic devices. They combine expertise in photonic integrated circuits, surface chemistry, and microfluidics to create plug-and-play detection systems that work outside the lab. Based in Wageningen, they sit at the crossroads of precision photonics and applied life sciences, making them relevant to both clinical diagnostics and agri-food monitoring.

What they specialise in

How they've shifted over time

SURFIX's H2020 journey starts in clinical oncology — as a third-party contributor to BIOCDx, they worked on bio-photonic companion diagnostics for cancer detection and treatment monitoring. From 2020 onward, their visible activity shifts decisively into the agri-food domain, with PHOTO-SENS applying the same core photonic sensing technology to detect salmon pathogens in aquaculture settings. The underlying photonics and surface chemistry expertise appears consistent across both periods; what changed is the application domain — from hospital oncology toward food production and biosecurity.

SURFIX appears to be moving from niche clinical diagnostics toward broader agri-food biosensing applications, suggesting future collaborations are most likely in food safety, aquaculture health monitoring, or environmental pathogen detection using photonic platforms.

How they like to work

SURFIX has not led any H2020 project — they enter consortia as a participant or third-party contributor, positioning themselves as a technology provider rather than a project driver. Their small consortium size (9 unique partners across 2 projects) and 4-country reach suggest they prefer focused, technically deep teams over broad multi-country networks. This profile fits an SME that brings a proprietary technology component into a consortium rather than managing the overall research direction.

SURFIX has collaborated with 9 unique partners across 4 countries in their two H2020 projects, a modest but meaningful international footprint for a company of this size. Their network spans both clinical and agri-food research contexts, reflecting their dual-domain technology applicability.

What sets them apart

SURFIX occupies a rare intersection: they are a photonics technology company with demonstrated application in both clinical oncology and agri-food biosecurity — two sectors that rarely share a single technology supplier. Their location in Wageningen, Europe's premier agri-food research hub, gives them privileged access to aquaculture and food-safety research ecosystems. For a consortium needing a miniaturized, manufacturable optical biosensing component — not a lab prototype — SURFIX's emphasis on scalability and high-volume manufacture sets them apart from purely academic photonics groups.

Highlights from their portfolio

• PHOTO-SENS
  Their primary funded project (EUR 881,690), PHOTO-SENS is notable for applying photonic integrated circuit technology to a practical aquaculture challenge — salmon pathogen detection — with an explicit focus on scalability and high-volume manufacture, indicating commercial readiness ambitions beyond the research phase.
• BIOCDx
  As a third-party contributor to a cancer companion diagnostics project, this role demonstrates SURFIX's early credibility in the clinical photonics space and their ability to supply specialized biosensing components to medically regulated diagnostic pipelines.